VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TARA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TARAProtara Therapeutics, Inc.
$4.16$161M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTARAQuarterly Financials

Protara Therapeutics, Inc. (TARA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Protara Therapeutics, Inc. (TARA) quarterly income statement — complete revenue, gross profit & net income history

TARA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold90K000000083K00000000000
COGS % of Revenue--------------------
Gross Profit-90K0000000-83K00000000000
Gross Margin %--------------------
Gross Profit Growth %----100%---------------
Operating Expenses19.54M19.08M14.76M16.59M14.12M14.31M12.33M10.66M11.77M11.04M10.7M12.14M9.73M39.51M7.97M8.71M10.87M10.29M10.83M12.79M
OpEx % of Revenue--------------------
Selling, General & Admin6.07M5.96M5.17M5.82M4.98M4.81M4.26M4.27M4.1M4.66M4.48M4.89M4.59M5M4.51M5.62M5.61M6.22M6.74M6.91M
SG&A % of Revenue--------------------
Research & Development13.47M13.12M9.59M10.77M9.15M9.5M8.07M6.39M7.67M6.38M6.22M7.25M5.14M4.99M3.47M3.08M5.27M4.07M4.09M5.89M
R&D % of Revenue--------------------
Other Operating Expenses00000000000001000K000000
Operating Income-19.63M-19.08M-14.76M-16.59M-14.12M-14.31M-12.33M-10.66M-11.85M-11.04M-10.7M-12.14M-9.73M-39.51M-7.97M-8.71M-10.87M-10.29M-10.83M-12.79M
Operating Margin %--------------------
Operating Income Growth %-38.98%-33.31%-19.71%-55.58%-19.18%-29.63%-15.23%12.18%-21.77%72.05%-34.19%-39.46%10.5%-284.07%26.37%31.95%19.93%-14.86%-34.33%-76.06%
EBITDA-19.54M-18.99M-14.67M-16.49M-14.04M-14.23M-12.25M-10.58M-11.77M-10.93M-10.62M-12.06M-9.65M-39.43M-7.91M-8.65M-10.82M-10.23M-10.14M-12.74M
EBITDA Margin %--------------------
EBITDA Growth %-39.16%-33.42%-19.81%-55.87%-19.32%-30.14%-15.3%12.3%-21.88%72.27%-34.27%-39.41%10.75%-285.36%22.01%32.07%20.15%-15.08%-26.22%-75.83%
D&A (Non-Cash Add-back)90K93K88K98K83K82K84K83K83K107K79K78K77K75K64K53K56K54K688K55K
EBIT-19.63M-19.08M-14.76M-16.59M-14.12M-14.31M-12.33M-10.66M-11.85M-11.04M-10.7M-12.14M-9.73M-9.99M-7.42M-8.19M-10.35M-8.31M-10.28M-12.28M
Net Interest Income1.84M1.5M1.5M1.61M1.72M1.15M1.1M1.14M747K814K838K842K687K525K283K166K119K59K53K10K
Interest Income1.84M1.5M1.5M1.61M1.72M1.15M1.1M1.14M747K814K838K842K687K632K557K512K529K59K547K513K
Interest Expense0000000000000107K274K346K410K-494K503K
Other Income/Expense1.85M1.77M1.5M1.63M2.21M1.54M1.11M1.15M756K820K840K846K687K542K283K166K119K59K53K10K
Pretax Income-17.78M-17.31M-13.26M-14.96M-11.91M-12.77M-11.22M-9.51M-11.1M-10.22M-9.86M-11.29M-9.04M-38.97M-7.69M-8.54M-10.76M-10.23M-10.78M-12.78M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-17.78M-17.31M-13.26M-14.96M-11.91M-12.77M-11.22M-9.51M-11.1M-10.22M-9.86M-11.29M-9.04M-38.97M-7.69M-8.54M-10.76M-10.23M-10.78M-12.78M
Net Margin %--------------------
Net Income Growth %-49.25%-35.54%-18.17%-57.26%-7.38%-24.93%-13.78%15.77%-22.66%73.77%-28.2%-32.26%15.9%-280.98%28.64%33.2%20.13%-16.13%-35.22%-79.02%
Net Income (Continuing)-17.78M-17.31M-13.26M-14.96M-11.91M-12.77M-11.22M-9.51M-11.1M-10.22M-9.86M-11.29M-9.04M-38.97M-7.69M-8.54M-10.76M-10.23M-10.78M-12.78M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.42-0.38-0.31-0.35-0.29-0.48-0.50-0.45-0.97-0.90-0.87-1.00-0.74-3.45-0.66-0.73-0.95-0.91-0.96-1.14
EPS Growth %-44.83%20.83%38%22.22%70.1%46.67%42.53%55%-31.08%73.91%-31.82%-36.99%22.11%-279.12%31.25%35.96%20.83%-16.67%23.81%6.56%
EPS (Basic)-0.42-0.38-0.31-0.35-0.29-0.48-0.50-0.45-0.97-0.90-0.87-1.00-0.74-3.45-0.66-0.73-0.95-0.91-0.96-1.14
Diluted Shares Outstanding42.84M46.04M42.27M42.27M40.71M26.43M22.33M21.23M11.42M11.36M11.35M11.31M11.3M11.27M11.27M11.26M11.25M11.24M11.24M11.23M
Basic Shares Outstanding42.84M46.04M42.27M42.27M40.71M26.43M22.33M21.23M11.42M11.36M11.35M11.31M11.3M11.27M11.27M11.26M11.25M11.24M11.24M11.23M
Dividend Payout Ratio--------------------